脾脏切除术后的血栓治疗进展
Progress in the Treatment of Thrombus after Splenectomy
摘要: 脾切除术后，各类血栓发生率高，若合并免疫功能下降、凶险性感染等，严重影响病人预后甚至危及生命。本文总结了相关研究，对脾切除术后血栓形成的危险因素，以及相关检查、治疗、用药等进行系统阐述。旨在方便广大临床工作者更好的了解脾切除术后血栓的防治方法。准确把握抗凝时机，改善患者预后。
Abstract: After splenectomy, the incidence of all kinds of thrombectomy is high, if the combination of immune function decline, dangerous infection, etc., seriously affect the prognosis of patients and even en-danger life. This paper summarizes relevant studies and systematically expounds the risk factors of thrombosis after splenectomy, as well as related examination, treatment and medication. The aim is to facilitate clinical workers to understand the treatment and prevention of thrombus after sple-nectomy. It accurately grasps the timing of anticoagulation, reduces the serious consequences caused by thrombosis, and improves the prognosis of patients.
文章引用：田思运, 秦磊. 脾脏切除术后的血栓治疗进展[J]. 临床医学进展, 2023, 13(10): 16833-16839. https://doi.org/10.12677/ACM.2023.13102357

参考文献

[1] Morris, T.A., Marsh, J.J., Chiles, P.G., et al. (2006) Fibrin Derived from Patients with Chronic Thromboembolic Pul-monary Hypertension Is Resistant to Lysis. American Journal of Respiratory and Critical Care Medicine, 173, 1270- 1275. [Google Scholar] [CrossRef] 
[2] 刘双池, 张登勇, 庞青, 等. 腹腔镜脾切除联合贲门周围血管离断术治疗门脉高压症的临床研究[J]. 肝胆外科杂志, 2021, 29(2): 118-122.
[3] Yamada, S., Morine, Y., Imura, S., et al. (2016) Liver Regeneration after Splenectomy in Patients with Liver Cirrhosis. Hepatology Research, 46, 443-449. [Google Scholar] [CrossRef] [PubMed]
[4] 张延娟, 吴广迎, 卢艳丽, 等. 不同术式治疗危险性EGVB患者远期生存状况比较及其影响因素分析[J]. 临床急诊杂志, 2023, 24(9): 476-482.
[5] 王仲恺, 张秩源, 徐浩, 等. TIPS治疗脾切除联合断流术后复发性门静脉高压伴上消化道出血的疗效分析[J]. 中华肝胆外科杂志, 2022, 28(2): 117-121.
[6] 陈翔. 完全腹腔镜、手助腹腔镜及开腹脾切除术治疗创伤性脾破裂的疗效比较与分析的临床研究[D]: [硕士学位论文]. 南昌: 南昌大学, 2020.
[7] Lai, W., Lu, S.C., Li, G.Y., et al. (2012) Anticoagulation Therapy Prevents Portal-Splenic Vein Thrombosis after Splenectomy with Gastroesophageal Devascularization. World Journal of Gastroenterology, 18, 3443-3450. [Google Scholar] [CrossRef] [PubMed]
[8] Kuypers, F.A., Yuan, J., Lewis, R.A., et al. (1998) Membrane Phospholipid Asymmetry in Human Thalassemia. Blood, 91, 3044-3051. [Google Scholar] [CrossRef] 
[9] Davis, P.J., Davis, F.B. and Mousa, S.A. (2009) Thyroid Hormone-Induced Angiogenesis. Current Cardiology Reviews, 5, 12-16. [Google Scholar] [CrossRef] [PubMed]
[10] Klein, I. and Danzi, S. (2016) Thyroid Disease and the Heart. Current Problems in Cardiology, 41, 65-92. [Google Scholar] [CrossRef] [PubMed]
[11] Richter, M.J., Sommer, N., Schermuly, R., et al. (2016) The Prognostic Impact of Thyroid Function in Pulmonary Hypertension. The Journal of Heart and Lung Transplantation, 35, 1427-1434. [Google Scholar] [CrossRef] [PubMed]
[12] Franchini, M. (2006) Hemostatic Changes in Thyroid Diseases: Haemostasis and Thrombosis. Hematology, 11, 203- 208. [Google Scholar] [CrossRef] [PubMed]
[13] Homoncik, M., Gessl, A., Ferlitsch, A., et al. (2007) Altered Platelet Plug Formation in Hyperthyroidism and Hypothyroidism. The Journal of Clinical Endocrinology & Metabolism, 92, 3006-3012. [Google Scholar] [CrossRef] [PubMed]
[14] Bick, R.L. (2003) Cancer-Associated Thrombosis. The New England Journal of Medicine, 349, 109-111. [Google Scholar] [CrossRef] 
[15] Smith, J.A. (2005) Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis. Journal of Urology, 174, 1300. [Google Scholar] [CrossRef] [PubMed]
[16] Pepke-Zaba, J., Delcroix, M., Lang, I., et al. (2011) Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results from an International Prospective Registry. Cir-culation, 124, 1973-1981. [Google Scholar] [CrossRef] 
[17] Blom, J.W., Osanto, S. and Rosendaal, F.R. (2004) The Risk of a Venous Thrombotic Event in Lung Cancer Patients: Higher Risk for Adenocarcinoma than Squamous Cell Carcinoma. Journal of Thrombosis and Haemostasis, 2, 1760- 1765. [Google Scholar] [CrossRef] [PubMed]
[18] Lang, I.M., Simonneau, G., Pepke-Zaba, J.W., et al. (2013) Factors Associated with Diagnosis and Operability of Chronic Thromboembolic Pulmonary Hypertension. A Case-Control Study. Thrombosis and Haemostasis, 110, 83-91. [Google Scholar] [CrossRef] 
[19] Ignatescu, M., Kostner, K., Zorn, G., et al. (1998) Plasma Lp(a) Levels Are Increased in Patients with Chronic Thromboembolic Pulmonary Hypertension. Thrombosis and Haemostasis, 80, 231-232. [Google Scholar] [CrossRef] 
[20] Thistlethwaite, P.A., Mo, M., Madani, M.M., et al. (2002) Operative Classification of Thromboembolic Disease Determines Outcome after Pulmonary Endarterectomy. The Journal of Tho-racic and Cardiovascular Surgery, 124, 1203- 1211. [Google Scholar] [CrossRef] [PubMed]
[21] Frey, M.K., Alias, S., Winter, M.P., et al. (2014) Splenectomy Is Modifying the Vascular Remodeling of Thrombosis. Journal of the American Heart Association, 3, e000772. [Google Scholar] [CrossRef] 
[22] Khan, P.N., Nair, R.J., Olivares, J., et al. (2009) Postsplenectomy Reactive Thrombocytosis. Proceedings (Baylor University. Medical Center), 22, 9-12. [Google Scholar] [CrossRef] [PubMed]
[23] Zhao, C.Q., Lyu, J. and Xu, L.M. (2019) Re-search Progress of Cirrhosis with Portal Vein Thrombosis. Chinese Journal of Hepatology, 27, 933-937.
[24] Ding, H., Zhang, Y., Zhao, L., et al. (2020) What Intervention Regimen Is Most Effective Prevention for Portal Venous System Thrombosis after Splenectomy in Cirrhotics Patients with Portal Hypertension? Systematic Review and Network Me-ta-Analysis. Pharmacological Research, 157, Article ID: 104825. [Google Scholar] [CrossRef] [PubMed]
[25] 曹顺勇. 脾切除术后血栓形成的原因、诊治及预防对策[J]. 中国医学创新, 2010, 7(1): 83-84.
[26] Lang, I.M., Campean, I.A., Sadushi-Kolici, R., et al. (2021) Chronic Thromboembolic Disease and Chronic Thromboembolic Pul-monary Hypertension. Clinics in Chest Medicine, 42, 81-90. [Google Scholar] [CrossRef] [PubMed]
[27] Kawanaka, H., Akahoshi, T., Kinjo, N., et al. (2014) Effect of Lap-aroscopic Splenectomy on Portal Haemodynamics in Patients with Liver Cirrhosis and Portal Hypertension. British Journal of Surgery, 101, 1585-1593. [Google Scholar] [CrossRef] [PubMed]
[28] Patel, A.G., Parker, J.E., Wallwork, B., et al. (2003) Massive Splenomegaly Is Associated with Significant Morbidity after Laparoscopic Splenectomy. Annals of Surgery, 238, 235-240. [Google Scholar] [CrossRef] [PubMed]
[29] 匡洁, 杨卫平, 陈皓, 等. 门静脉高压症术后门静脉血栓形成的危险因素分析[J]. 外科理论与实践, 2012, 17(6): 634-638.
[30] 姚戈冰, 鲁建国. 门静脉血栓的发病机制及诊治[J]. 肝胆外科杂志, 2009, 17(2): 151-154.
[31] Kinjo, N., Kawanaka, H., Akahoshi, T., et al. (2010) Risk Factors for Portal Venous Thrombosis after Splenectomy in Patients with Cirrhosis and Portal Hypertension. British Journal of Surgery, 97, 910-916. [Google Scholar] [CrossRef] [PubMed]
[32] Yoshida, M., Watanabe, Y., Horiuchi, A., et al. (2009) Portal and Splenic Venous Thrombosis after Splenectomy in Patients with Hypersplenism. Hepatogastroenterology, 56, 538-541.
[33] Dai, J., Qi, X., Peng, Y., et al. (2015) Association between D-Dimer Level and Portal Venous System Thrombosis in Liver Cirrhosis: A Retrospective Observational Study. International Journal of Clinical and Experimental Medicine, 8, 15296-15301.
[34] 郑波, 廖东旭, 杨训, 等. 门静脉高压性脾功能亢进患者腹腔镜脾切除术后并发门静脉系统血栓形成的危险因素研究[J]. 中国普外基础与临床杂志, 2018, 25(4): 438-443.
[35] 胡方方, 石瑜, 王广军, 等. 血清P-选择素、D-二聚体、神经元特异性烯醇化酶水平与急性脑梗死患者认知功能的关系[J]. 中国现代医药杂志, 2023, 25(8): 20-24.
[36] Primignani, M., Martinelli, I., Bucciarelli, P., et al. (2005) Risk Factors for Thrombophilia in Extrahepatic Portal Vein Obstruction. Hepatology, 41, 603-608. [Google Scholar] [CrossRef] [PubMed]
[37] Webster, G.J., Burroughs, A.K. and Riordan, S.M. (2005) Review Article: Portal Vein Thrombosis—New Insights into Aetiology and Management. Alimentary Pharmacology & Therapeutics, 21, 1-9. [Google Scholar] [CrossRef] [PubMed]
[38] Amitrano, L., Guardascione, M.A., Brancaccio, V., et al. (2004) Risk Factors and Clinical Presentation of Portal Vein Thrombosis in Patients with Liver Cirrhosis. Journal of Hepatology, 40, 736-741. [Google Scholar] [CrossRef] [PubMed]
[39] Francoz, C., Belghiti, J., Vilgrain, V., et al. (2005) Splanchnic Vein Thrombosis in Candidates for Liver Transplantation: Usefulness of Screening and Anticoagulation. Gut, 54, 691-697. [Google Scholar] [CrossRef] [PubMed]
[40] Manouchehri, N., Kaneva, P., Séguin, C., et al. (2016) Screening for Thrombophilia Does Not Identify Patients at Risk of Portal or Splenic Vein Thrombosis Following Laparoscopic Sple-nectomy. Surgical Endoscopy, 30, 2119-2126. [Google Scholar] [CrossRef] [PubMed]
[41] Pietrabissa, A., Moretto, C., Antonelli, G., et al. (2004) Throm-bosis in the Portal Venous System after Elective Laparoscopic Splenectomy. Surgical Endoscopy, 18, 1140-1143. [Google Scholar] [CrossRef] [PubMed]
[42] Sabbagh, A., Keikhaei, B., Joorabian, M., et al. (2019) Retrospec-tive Study of the Incidence of Portal Vein Thrombosis after Splenectomy in Hematological Disorders: Risk Factors and Clinical Presentation. Blood Cells, Molecules, and Diseases, 74, 1-4. [Google Scholar] [CrossRef] [PubMed]
[43] 贺莎莎, 范晓棠, 石绣江, 等. 肝硬化门静脉高压症脾切除术后发生门静脉血栓的风险因素及其预测模型的建立[J]. 中国普通外科杂志, 2016, 25(12): 1766-1772.
[44] Han, J.Y., Choi, D.H., Choi, S.W., et al. (2013) Stroke or Coronary Artery Disease Prediction from Mean Platelet Volume in Patients with Type 2 Diabetes Mellitus. Platelets, 24, 401-406. [Google Scholar] [CrossRef] [PubMed]
[45] 马焕林, 郑毅勇, 邱开封, 等. 血清P选择素、AKP、APCR联合检测对下肢创伤骨折术后深静脉血栓的临床价值研究[J]. 中国骨与关节杂志, 2023, 12(6): 429-432.
[46] 孙晓琪, 王育珊, 刘忠民, 等. 急性冠脉综合征患者血清P选择素的动态变化及其临床意义探讨[J]. 中国急救复苏与灾害医学杂志, 2008, 3(3): 141-144.
[47] 魏云海, 尹磊, 王雁, 等. P-选择素对腹腔镜脾切除术后门静脉血栓形成的早期预测价值[J]. 腹腔镜外科杂志, 2018, 23(12): 927-930.
[48] Wang, L., Liu, G.J., Chen, Y.X., et al. (2010) Combined Use of D-Dimer and P-Selectin for the Diagnosis of Splenic or Portal Vein Thrombosis Following Splenectomy. Thrombosis Research, 125, e206-e209. [Google Scholar] [CrossRef] [PubMed]
[49] Cheng, Z., Li, J.W., Chen, J., et al. (2014) Therapeutic Effects of Laparoscopic Splenectomy and Esophagogastric Devascularization on Liver Cirrhosis and Portal Hypertension in 204 Cases. Journal of Laparoendoscopic & Advanced Surgical Techniques A, 24, 612-616. [Google Scholar] [CrossRef] [PubMed]
[50] Radkowiak, D., Zychowicz, A., Lasek, A., et al. (2018) 20 Years’ Ex-perience with Laparoscopic Splenectomy. Single Center Outcomes of a Cohort Study of 500 Cases. International Journal of Surgery, 52, 285-292. [Google Scholar] [CrossRef] [PubMed]
[51] 宁克, 殷香保. 门静脉高压症行腹腔镜脾切除术后门静脉系统血栓形成预测因子的研究进展[J]. 中国普通外科杂志, 2020, 29(8): 1012-1017.
[52] 虞哲科, 王晶晶, 邱振明, 等. 药物治疗门静脉系统血栓形成的疗效[J]. 温州医科大学学报, 2018, 48(5): 383-384+ 391.
[53] 韩宗霖, 孙岩, 孔祥骞, 等. 脾切除术后肠系膜上静脉血栓形成治疗体会[J]. 解放军医药杂志, 2013, 25(6): 39-40+ 49.
[54] 许朱定, 张海斌, 沈翔, 等. 非手术治疗门静脉血栓形成56例治疗体会[J]. 西南国防医药, 2013, 23(9): 994-996.
[55] Wu, S., Wu, Z., Zhang, X., et al. (2015) The Incidence and Risk Factors of Portal Vein System Thrombosis after Splenectomy and Pericardial Devascularization. Turkish Journal of Gastroenterology, 26, 423-428. [Google Scholar] [CrossRef] [PubMed]
[56] 赵舸, 栗宏红, 刘冲, 等. 外伤性脾切除患者术后门静脉血栓的预防性治疗[J]. 中国药物与临床, 2016, 16(7): 1057-1059.
[57] Cheng, Z., Yu, F., Tian, J., et al. (2015) A Comparative Study of Two Anti-Coagulation Plans on the Prevention of PVST after Laparoscopic Splenectomy and Esophagogastric Devascularization. Journal of Thrombosis and Thrombolysis, 40, 294-301. [Google Scholar] [CrossRef] [PubMed]
[58] 罗金泉, 袁富煌, 李静远, 等. 腹腔镜脾切除术后阿司匹林联合双嘧达莫用药对血小板指标的影响[J]. 沈阳药科大学学报, 2021, 38(S1): 74+76.
[59] 梁刚, 王智翔, 何盟国, 等. 早期联合抗凝对脾切断流术后门静脉系统血栓形成的预防效果[J]. 临床医学研究与实践, 2019, 4(4): 5-6+9.
[60] 魏鹏, 王领, 梁刚, 等. 阿司匹林早期直肠给药在肝硬化门静脉高压症术后的应用效果[J]. 临床医学研究与实践, 2019, 4(6): 19-20.
[61] Nakayasu, H., Maeda, M., Soda, T., et al. (2003) The Antiplatelet Aggregation Effects of Aspirin Suppositories. Cerebrovascular Diseases, 16, 31-35. [Google Scholar] [CrossRef] [PubMed]
[62] 余志平, 高述松. 联合式护理干预对脾切除术后深静脉血栓预防的效果研究[J]. 中国继续医学教育, 2020, 12(20): 188-191.

为你推荐